The Latest Breaking News from Nasdaq

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

At the annual meeting for Warren Buffett’s Berkshire Hathaway (NYSE: BRK-A)(NYSE: BRK-B), it was announced his firm

Recently, Vir Biotechnology Inc (NASDAQ:VIR) announced updates on its expansive hepatitis portfolio, including VIR-2218 which is part of a collaboration with Alnylam Pharmaceuticals Inc (NASDAQ:ALNY), and VIR-3434, a monoclonal antibody (mAb).  The key highlight of the event was the initial data presented from the Phase 2 MARCH trial of VIR-2218 + VIR-3434 in patients with…

Nikola Corp (NASDAQ:NKLA) disclosed that an institutional investor has agreed to make a $200 million investment by purchasing Convertible Senior Notes. Funds advised by Antara Capital LP have agreed to purchase a $200 million aggregate amount of Convertible Senior Notes due 2026. The Notes will bear interest at a rate of 8.00% if…

Moderna Inc's (NASDAQ:MRNA) chief medical officer said that its COVID-19 vaccine for children under six years old would be ready for review by the FDA panel when it meets in June. "I think the FDA now has all of the core fundamental data they need to be able to begin an application review.…

Endo International plc (NASDAQ: ENDP) has acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc, a subsidiary of Nevakar Inc.

The FDA has instituted a clinical hold on Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) VX-880 Phase 1/2 study due to a determination that there is insufficient information to support dose escalation with the product. VX-880 is an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for type 1 diabetes (T1D).  Three patients have been…

The European Commission has approved Horizon Therapeutics plc's (NASDAQ:HZNP) Uplizna (inebilizumab) as monotherapy for neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 immunoglobulin G seropositive (AQP4-IgG+). NMOSD is an autoimmune disease that attacks the optic nerve, spinal cord, brain, and brain stem. In the N-MOmentum pivotal clinical trial, Uplizna demonstrated a significant reduction…

Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc (NASDAQ:BIIB) have initiated a rolling submission of a marketing application to the FDA for zuranolone in major depressive disorder (MDD).  Zuranolone is an investigational two-week, once-daily oral drug developed for MDD and postpartum depression (PPD).  The companies have submitted the nonclinical module and plan to submit the remaining…

Farmmi Inc (NASDAQ:FAMI) has won a new North American sales order to Vancouver, Canada. The order is for dried Shiitake mushrooms. The financial terms were not disclosed. “With the reopening of most cities worldwide following COVID shutdowns, we are seeing a pick-up from both consumption at restaurants and in-home cooking,” said Chairwoman and…

Brussels regulators have accused Apple Inc (NASDAQ:AAPL) of abusing its dominant position in mobile payments to limit rivals’ access to contactless technology. Apple could face a fine of up to 10% of its global turnover or $36.6 billion based on its 2021 revenue for the alleged breach of EU competition law. Also Read: Apple To…